Clinical trial
Intranasal TXA for Anterior Epistaxis in the Emergency Department
NCT04054687 is registered in ClinicalTrials.gov with Mercy Health Ohio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal TXA for Anterior Epistaxis in the Emergency Department
- Lead sponsor
- Mercy Health Ohio
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- November 7, 2019
- Completion date
- May 31, 2021
- Enrollment
- 86 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.